128 related articles for article (PubMed ID: 21507789)
1. Drug-induced QTc-interval prolongation in the intensive care unit: incidence and predictors.
Ng TM; Olsen KM; McCartan MA; Puumala SE; Speidel KM; Miller MA; Sears TD
J Pharm Pract; 2010 Feb; 23(1):19-24. PubMed ID: 21507789
[TBL] [Abstract][Full Text] [Related]
2. Pharmacist monitoring of QTc interval-prolonging medications in critically ill medical patients: a pilot study.
Ng TM; Bell AM; Hong C; Hara JM; Touchette DR; Danskey KN; Lindsay TT; Puumala SE
Ann Pharmacother; 2008 Apr; 42(4):475-82. PubMed ID: 18319393
[TBL] [Abstract][Full Text] [Related]
3. Methadone maintenance, QTc and torsade de pointes: who needs an electrocardiogram and what is the prevalence of QTc prolongation?
Mayet S; Gossop M; Lintzeris N; Markides V; Strang J
Drug Alcohol Rev; 2011 Jul; 30(4):388-96. PubMed ID: 21355918
[TBL] [Abstract][Full Text] [Related]
4. Conduction disturbances associated with administration of butyrophenone antipsychotics in the critically ill: a review of the literature.
Lawrence KR; Nasraway SA
Pharmacotherapy; 1997; 17(3):531-7. PubMed ID: 9165555
[TBL] [Abstract][Full Text] [Related]
5. Frequency of electrocardiogram testing among HIV-infected patients at risk for medication-induced QTc prolongation.
Patel N; Veve M; Kwon S; McNutt LA; Fish D; Miller CD
HIV Med; 2013 Sep; 14(8):463-71. PubMed ID: 23506263
[TBL] [Abstract][Full Text] [Related]
6. Psychotropic drugs associated with corrected QT interval prolongation.
van Noord C; Straus SM; Sturkenboom MC; Hofman A; Aarnoudse AJ; Bagnardi V; Kors JA; Newton-Cheh C; Witteman JC; Stricker BH
J Clin Psychopharmacol; 2009 Feb; 29(1):9-15. PubMed ID: 19142100
[TBL] [Abstract][Full Text] [Related]
7. Literature review and pilot studies of the effect of QT correction formulas on reported beta2-agonist-induced QTc prolongation.
Milic M; Bao X; Rizos D; Liu F; Ziegler MG
Clin Ther; 2006 Apr; 28(4):582-90. PubMed ID: 16750469
[TBL] [Abstract][Full Text] [Related]
8. QTc-interval prolongation associated with slow intravenous erythromycin lactobionate infusions in critically ill patients: a prospective evaluation and review of the literature.
Tschida SJ; Guay DR; Straka RJ; Hoey LL; Johanning R; Vance-Bryan K
Pharmacotherapy; 1996; 16(4):663-74. PubMed ID: 8840374
[TBL] [Abstract][Full Text] [Related]
9. Frequency and prognostic significance of QT prolongation in chronic renal failure patients.
Voiculescu M; Ionescu C; Ismail G
Rom J Intern Med; 2006; 44(4):407-17. PubMed ID: 18386617
[TBL] [Abstract][Full Text] [Related]
10. Onsite QTc interval screening for patients in methadone maintenance treatment.
Fareed A; Vayalapalli S; Byrd-Sellers J; Casarella J; Drexler K; Amar R; Smith-Cox J; Lutchman TS
J Addict Dis; 2010 Jan; 29(1):15-22. PubMed ID: 20390695
[TBL] [Abstract][Full Text] [Related]
11. The prevalence and factors associated with QTc prolongation among emergency department patients.
Seftchick MW; Adler PH; Hsieh M; Wolfson AB; Chan ST; Webster BW; Frattaroli GD
Ann Emerg Med; 2009 Dec; 54(6):763-8. PubMed ID: 19419793
[TBL] [Abstract][Full Text] [Related]
12. Dynamics of the QTc interval over a 24-h dose interval after start of intravenous ciprofloxacin or low-dose erythromycin administration in ICU patients.
Berger FA; van Weteringen W; van der Sijs H; Hunfeld NGM; Bunge JJH; de Groot NMS; van den Bemt PMLA; van Gelder T
Pharmacol Res Perspect; 2021 Dec; 9(6):e00865. PubMed ID: 34697899
[TBL] [Abstract][Full Text] [Related]
13. QTc interval prolongation in critically ill patients: Prevalence, risk factors and associated medications.
Fernandes FM; Silva EP; Martins RR; Oliveira AG
PLoS One; 2018; 13(6):e0199028. PubMed ID: 29898002
[TBL] [Abstract][Full Text] [Related]
14. Relation of increased short-term variability of QT interval to congenital long-QT syndrome.
Hinterseer M; Beckmann BM; Thomsen MB; Pfeufer A; Dalla Pozza R; Loeff M; Netz H; Steinbeck G; Vos MA; Kääb S
Am J Cardiol; 2009 May; 103(9):1244-8. PubMed ID: 19406266
[TBL] [Abstract][Full Text] [Related]
15. QTc prolongation and antipsychotic medications in a sample of 1017 patients with schizophrenia.
Ozeki Y; Fujii K; Kurimoto N; Yamada N; Okawa M; Aoki T; Takahashi J; Ishida N; Horie M; Kunugi H
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Mar; 34(2):401-5. PubMed ID: 20079791
[TBL] [Abstract][Full Text] [Related]
16. The incidence, predictors and outcomes of QTc prolongation in critically ill patients.
Russell H; Churilov L; Toh L; Eastwood GM; Bellomo R
J Crit Care; 2019 Dec; 54():244-249. PubMed ID: 31630074
[TBL] [Abstract][Full Text] [Related]
17. A detailed description and assessment of outcomes of patients with hospital recorded QTc prolongation.
Laksman Z; Momciu B; Seong YW; Burrows P; Conacher S; Manlucu J; Leong-Sit P; Gula LJ; Skanes AC; Yee R; Klein GJ; Krahn AD
Am J Cardiol; 2015 Apr; 115(7):907-11. PubMed ID: 25665761
[TBL] [Abstract][Full Text] [Related]
18. Incidence and outcomes of long QTc in acute medical admissions.
Mahmud R; Gray A; Nabeebaccus A; Whyte MB
Int J Clin Pract; 2018 Nov; 72(11):e13250. PubMed ID: 30222237
[TBL] [Abstract][Full Text] [Related]
19. Beat-to-beat variability of QT intervals is increased in patients with drug-induced long-QT syndrome: a case control pilot study.
Hinterseer M; Thomsen MB; Beckmann BM; Pfeufer A; Schimpf R; Wichmann HE; Steinbeck G; Vos MA; Kaab S
Eur Heart J; 2008 Jan; 29(2):185-90. PubMed ID: 18156612
[TBL] [Abstract][Full Text] [Related]
20. Development of a risk score for QTc-prolongation: the RISQ-PATH study.
Vandael E; Vandenberk B; Vandenberghe J; Spriet I; Willems R; Foulon V
Int J Clin Pharm; 2017 Apr; 39(2):424-432. PubMed ID: 28281228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
